Carfilzomib, a second-generation proteasome inhibitor, is widely used in the treatment of multiple myeloma. This synthetic tetra-peptide epoxyketone derivative binds irreversibly to the 20 S ...
Course Topics Include: – FDA, ICH and USP Validation Requirements – Applying Validation Studies Consistent with Method Purpose – GMP Compliance during Validation – Validation Acceptance Criteria – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results